The board of Guidant Corp., the target of a bidding war between Johnson & Johnson and Boston Scientific Corp., was expected to meet on Tuesday to weigh Boston Scientific’s formal offer, said one source familiar with the situation.
*For more on this story,
read the full Reuters article.
